These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25220208)

  • 1. Occult nodal disease in patients with non-small-cell lung cancer who are suitable for stereotactic ablative body radiation.
    Robson JM; Vaidyanathan S; Cheyne L; Snee M; Franks K; Callister ME
    Clin Lung Cancer; 2014 Nov; 15(6):466-9. PubMed ID: 25220208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Nodal Staging of Stereotactic Ablative Body Radiotherapy Patients.
    Vial MR; Khan KA; O'Connell O; Peng SA; Gomez DR; Chang JY; Rice DC; Mehran R; Jimenez CJ; Grosu HB; Ost DE; Eapen GA
    Ann Thorac Surg; 2017 May; 103(5):1600-1605. PubMed ID: 28027732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undetected lymph node metastases in presumed early stage NSCLC SABR patients.
    Cerra-Franco A; Diab K; Lautenschlaeger T
    Expert Rev Anticancer Ther; 2016 Aug; 16(8):869-75. PubMed ID: 27279087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.
    Akthar AS; Ferguson MK; Koshy M; Vigneswaran WT; Malik R
    Technol Cancer Res Treat; 2017 Feb; 16(1):15-21. PubMed ID: 26792491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of mediastinal staging in potential candidates for stereotactic radiosurgery of the chest.
    Sarwate D; Sarkar S; Krimsky WS; Burgan CM; Patel K; Evans R; Harley DP
    J Thorac Cardiovasc Surg; 2012 Jul; 144(1):81-6. PubMed ID: 22498085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer.
    Shingyoji M; Nakajima T; Yoshino M; Yoshida Y; Ashinuma H; Itakura M; Tatsumi K; Iizasa T
    Ann Thorac Surg; 2014 Nov; 98(5):1762-7. PubMed ID: 25149044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR).
    Dhaliwal I; Kassirian S; Mitchell MA; Qiabi M; Warner A; Louie AV; Wong HH; McDonald CM; Rajchgot J; Palma DA
    BMC Cancer; 2022 Apr; 22(1):468. PubMed ID: 35484614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
    Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
    Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endobronchial ultrasound-guided transbronchial needle aspiration for systematic nodal staging of lung cancer in patients with N0 disease by computed tomography and integrated positron emission tomography-computed tomography.
    Ong P; Grosu H; Eapen GA; Rodriguez M; Lazarus D; Ost D; Jimenez CA; Morice R; Bandi V; Tamara L; Cornwell L; Green L; Zhu A; Casal RF
    Ann Am Thorac Soc; 2015 Mar; 12(3):415-9. PubMed ID: 25584815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: potential value in the clinic.
    Li L; Ren S; Zhang Y; Guan Y; Zhao J; Liu J; Wang Q; Chen G; Chen H; Xiang J; Fu X
    Lung Cancer; 2013 Aug; 81(2):213-7. PubMed ID: 23664030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of mediastinoscopy in clinical stage I lung cancers at risk for occult mediastinal nodal metastases.
    Fernandez FG; Kozower BD; Crabtree TD; Force SD; Lau C; Pickens A; Krupnick AS; Veeramachaneni N; Patterson GA; Jones DR; Meyers BF
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):35-41, 42.e1. PubMed ID: 25439769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of endobronchial ultrasound-guided mediastinal lymph node biopsy in patients with non-small cell lung cancer.
    Lee BE; Kletsman E; Rutledge JR; Korst RJ
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):585-90. PubMed ID: 22154791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved staging using intraoperative ultrasound for mediastinal lymphadenectomy in non-small lung cancer surgery.
    Juričić J; Ilić N; Frleta Ilić N; Ilić D; Mrklić I; Pogorelić Z
    Surgeon; 2014 Aug; 12(4):191-4. PubMed ID: 24368191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Video-assisted thoracic surgery systematic mediastinal nodal dissection and stage migration: impact on clinical pathway.
    Amer K; Khan AZ; Singh N; Addis B; Jogai S; Harden S; Peebles C; Brown I
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1474-81. PubMed ID: 21497109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
    Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: Incidence and proposed risk factors.
    Wink KCJ; van Baardwijk A; Troost EGC; De Ruysscher D
    Cancer Treat Rev; 2017 May; 56():8-15. PubMed ID: 28437679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical with pathological nodal staging from systematic mediastinal lymph node dissection in early resectable non-small cell lung cancer.
    Chong CF; Khoo KL; Lim TK; Chang AY; Lim HL; Lee CN; Wong PS
    Singapore Med J; 2007 Jul; 48(7):620-4. PubMed ID: 17609822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.